208 related articles for article (PubMed ID: 21569559)
1. The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity.
Cimmino MA; Parodi M; Montecucco C; Caporali R
BMC Musculoskelet Disord; 2011 May; 12(1):94. PubMed ID: 21569559
[TBL] [Abstract][Full Text] [Related]
2. Treatment of polymyalgia rheumatica: a systematic review.
Hernández-Rodríguez J; Cid MC; López-Soto A; Espigol-Frigolé G; Bosch X
Arch Intern Med; 2009 Nov; 169(20):1839-50. PubMed ID: 19901135
[TBL] [Abstract][Full Text] [Related]
3. Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.
Devauchelle-Pensec V; Carvajal-Alegria G; Dernis E; Richez C; Truchetet ME; Wendling D; Toussirot E; Perdriger A; Gottenberg JE; Felten R; Fautrel BJ; Chiche L; Hilliquin P; Le Henaff C; Dervieux B; Direz G; Chary-Valckenaere I; Cornec D; Guellec D; Marhadour T; Nowak E; Saraux A
JAMA; 2022 Sep; 328(11):1053-1062. PubMed ID: 36125471
[TBL] [Abstract][Full Text] [Related]
4. Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable.
Devauchelle-Pensec V; Saraux L; Berthelot JM; De Bandt M; Cornec D; Guellec D; Marhadour T; Jousse-Joulin S; Gouillou M; Saraux A
Rheumatology (Oxford); 2018 Apr; 57(4):666-670. PubMed ID: 29346621
[TBL] [Abstract][Full Text] [Related]
5. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
[TBL] [Abstract][Full Text] [Related]
6. Predictors of glucocorticoid-free remission in patients with polymyalgia rheumatica treated with prednisolone.
Hattori K; Hirano Y; Kojima T
Int J Rheum Dis; 2020 Nov; 23(11):1581-1586. PubMed ID: 32996694
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice.
Cleuziou C; Binard A; De Bandt M; Berthelot JM; Saraux A
J Rheumatol; 2012 Feb; 39(2):310-3. PubMed ID: 22174199
[TBL] [Abstract][Full Text] [Related]
8. Medical management of polymyalgia rheumatica.
Gonzalez-Gay MA; Agudo M; Martinez-Dubois C; Pompei O; Blanco R
Expert Opin Pharmacother; 2010 May; 11(7):1077-87. PubMed ID: 20367535
[TBL] [Abstract][Full Text] [Related]
9. Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.
Dejaco C; Singh YP; Perel P; Hutchings A; Camellino D; Mackie S; Matteson EL; Dasgupta B
Ann Rheum Dis; 2015 Oct; 74(10):1808-17. PubMed ID: 26359489
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Devauchelle-Pensec V; Berthelot JM; Cornec D; Renaudineau Y; Marhadour T; Jousse-Joulin S; Querellou S; Garrigues F; De Bandt M; Gouillou M; Saraux A
Ann Rheum Dis; 2016 Aug; 75(8):1506-10. PubMed ID: 26929219
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid treatment and clinical outcomes in patients with polymyalgia rheumatica: A cohort study using routinely collected health data.
Tanaka Y; Tanaka S; Fukasawa T; Inokuchi S; Uenaka H; Kimura T; Takahashi T; Kato N
Joint Bone Spine; 2024 May; 91(3):105680. PubMed ID: 38143016
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
Cantini F; Salvarani C; Olivieri I; Macchioni L; Ranzi A; Niccoli L; Padula A; Boiardi L
Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
[TBL] [Abstract][Full Text] [Related]
13. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
[TBL] [Abstract][Full Text] [Related]
14. The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission.
Leeb BF; Rintelen B; Sautner J; Fassl C; Bird HA
Arthritis Rheum; 2007 Jun; 57(5):810-5. PubMed ID: 17530664
[TBL] [Abstract][Full Text] [Related]
15. Concordance and agreement between different activity scores in polymyalgia rheumatica.
D'Agostino J; Souki A; Lohse A; Carvajal Alegria G; Dernis E; Richez C; Truchetet ME; Wendling D; Toussirot E; Perdriger A; Gottenberg JE; Felten R; Fautrel B; Chiche L; Hilliquin P; Le Henaff C; Dervieux B; Direz G; Chary-Valckenaere I; Cornec D; Guellec D; Marhadour T; Nowak E; Saraux A; Devauchelle-Pensec V
RMD Open; 2024 Mar; 10(1):. PubMed ID: 38490696
[TBL] [Abstract][Full Text] [Related]
16. Sixth-month remission as a predictor for twelve-month remission in polymyalgia rheumatica.
Birra D; Bosello SL; Peluso G; Zoli A
Clin Exp Rheumatol; 2020; 38(3):436-441. PubMed ID: 31858957
[TBL] [Abstract][Full Text] [Related]
17. Polymyalgia rheumatica: inflammation suppression with low dose of methylprednisolone or modified-release prednisone.
Benucci M; Olivito B; Manfredi M; Meacci F; Infantino M; Li Gobbi F; Sarzi-Puttini P; Marcassa C; Atzeni F
Eur Rev Med Pharmacol Sci; 2015; 19(5):745-51. PubMed ID: 25807425
[TBL] [Abstract][Full Text] [Related]
18. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).
Leeb BF; Bird HA; Nesher G; Andel I; Hueber W; Logar D; Montecucco CM; Rovensky J; Sautner J; Sonnenblick M
Ann Rheum Dis; 2003 Dec; 62(12):1189-94. PubMed ID: 14644857
[TBL] [Abstract][Full Text] [Related]
19. Relapse in a population based cohort of patients with polymyalgia rheumatica.
Kremers HM; Reinalda MS; Crowson CS; Zinsmeister AR; Hunder GG; Gabriel SE
J Rheumatol; 2005 Jan; 32(1):65-73. PubMed ID: 15630727
[TBL] [Abstract][Full Text] [Related]
20. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
Salvarani C; Cantini F; Niccoli L; Macchioni P; Consonni D; Bajocchi G; Vinceti M; Catanoso MG; Pulsatelli L; Meliconi R; Boiardi L
Arthritis Rheum; 2005 Feb; 53(1):33-8. PubMed ID: 15696567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]